ATE269062T1 - Zeitgesteuert freisetzende dosierungsformen enthaltend ein kurz wirksames hypnotikum oder ein salz davon - Google Patents

Zeitgesteuert freisetzende dosierungsformen enthaltend ein kurz wirksames hypnotikum oder ein salz davon

Info

Publication number
ATE269062T1
ATE269062T1 AT00954518T AT00954518T ATE269062T1 AT E269062 T1 ATE269062 T1 AT E269062T1 AT 00954518 T AT00954518 T AT 00954518T AT 00954518 T AT00954518 T AT 00954518T AT E269062 T1 ATE269062 T1 AT E269062T1
Authority
AT
Austria
Prior art keywords
salt
short
time
dosage forms
release dosage
Prior art date
Application number
AT00954518T
Other languages
English (en)
Inventor
Gerard Alaux
Frederic Andre
Jean Ducassou
Gareth Lewis
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8242028&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE269062(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of ATE269062T1 publication Critical patent/ATE269062T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00954518T 1999-06-28 2000-06-27 Zeitgesteuert freisetzende dosierungsformen enthaltend ein kurz wirksames hypnotikum oder ein salz davon ATE269062T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99401605A EP1064937A1 (de) 1999-06-28 1999-06-28 Pharmazeutische Zusammensetzungen mit kontrollierten Freigabe enthaltend ein Hypnotikum mit kurzer Wirkung oder deren Salze
PCT/EP2000/006792 WO2001000181A2 (en) 1999-06-28 2000-06-27 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof

Publications (1)

Publication Number Publication Date
ATE269062T1 true ATE269062T1 (de) 2004-07-15

Family

ID=8242028

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00954518T ATE269062T1 (de) 1999-06-28 2000-06-27 Zeitgesteuert freisetzende dosierungsformen enthaltend ein kurz wirksames hypnotikum oder ein salz davon

Country Status (28)

Country Link
EP (2) EP1064937A1 (de)
JP (1) JP2003503340A (de)
KR (1) KR20020015064A (de)
CN (1) CN100415216C (de)
AR (1) AR024491A1 (de)
AT (1) ATE269062T1 (de)
AU (1) AU782162B2 (de)
BR (1) BR0011994A (de)
CA (1) CA2370556C (de)
CO (1) CO5190680A1 (de)
CZ (1) CZ20014640A3 (de)
DE (1) DE60011617T2 (de)
DK (1) DK1194132T3 (de)
ES (1) ES2222223T3 (de)
HK (1) HK1043057B (de)
HU (1) HU227810B1 (de)
IL (1) IL146928A0 (de)
MX (1) MXPA01013212A (de)
NO (1) NO20016283L (de)
NZ (1) NZ515997A (de)
PL (1) PL201777B1 (de)
PT (1) PT1194132E (de)
SI (1) SI1194132T1 (de)
SK (1) SK285347B6 (de)
TR (1) TR200103594T2 (de)
TW (1) TWI285118B (de)
WO (1) WO2001000181A2 (de)
ZA (1) ZA200110005B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1064938A1 (de) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmazeutische Dosierungsformen zur kontrollierte Wirkstoffabgabe mit mindenstens ein pulsierendem Zeitverlauf
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
PT1206248E (pt) * 1999-08-26 2003-11-28 Neurocrine Biosciences Inc Composicoes sedativo-hipnoticas de libertacao controlada e metodos relacionados com os mesmos
US7811557B1 (en) * 2000-10-27 2010-10-12 Viacell, Inc. Methods for improving central nervous system functioning
JP2004525955A (ja) * 2001-04-05 2004-08-26 コッラジェネックス ファーマシューチカルス インコーポレイテッド テトラサイクリン化合物およびテトラサイクリン誘導体の制御された伝達
US20030130297A1 (en) 2001-07-06 2003-07-10 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
US8329216B2 (en) 2001-07-06 2012-12-11 Endo Pharmaceuticals Inc. Oxymorphone controlled release formulations
DE60223254T2 (de) 2001-07-06 2008-08-14 Penwest Pharmaceuticals Co. Verzögert freisetzende formulierungen von oxymorphon
KR20040073495A (ko) * 2001-12-19 2004-08-19 가부시키가이샤산와카가쿠켄큐쇼 방출제어형 성형품
PL371407A1 (en) * 2002-01-10 2005-06-13 Biovail Laboratories Inc. Sedative non-benzodiazepine formulations
EP1941878A1 (de) * 2002-01-10 2008-07-09 Biovail Laboratories International Srl Sedative Formulierungen ohne Benzodiazepin
US20030165566A1 (en) * 2002-01-10 2003-09-04 O'toole Edel Sedative non-benzodiazepine formulations
CA2503121A1 (en) * 2002-10-25 2004-05-13 Collegium Pharmaceutical, Inc. Pulsatile release compositions of milnacipran
JP4681843B2 (ja) * 2004-09-30 2011-05-11 日本臓器製薬株式会社 固形医薬製剤
GB0423964D0 (en) * 2004-10-28 2004-12-01 Jagotec Ag Dosage form
FR2887455B1 (fr) * 2005-06-28 2007-08-10 Sanofi Aventis Sa Formulation a liberation prolongee de principes actifs de medicaments
CA2629740A1 (en) * 2005-11-18 2007-06-14 Synthon B.V. Zolpidem tablets
AR056633A1 (es) * 2005-12-07 2007-10-17 Gador Sa Composiciones farmaceuticas de agentes hipnoticos de accion corta en forma de liberacion modificada y los procedimientos para preparar dichas formulaciones
US8309104B2 (en) * 2006-03-02 2012-11-13 Watson Pharmaceuticals, Inc. Oral controlled release formulation for sedative and hypnotic agents
KR20070091960A (ko) * 2006-03-08 2007-09-12 주식회사종근당 졸피뎀 또는 그의 염을 포함하는 안전한 제어방출형 제제조성물
AU2013202441B2 (en) * 2006-04-26 2016-02-25 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
AU2007242077B2 (en) * 2006-04-26 2013-11-14 Alphapharm Pty Ltd Controlled release formulations comprising uncoated discrete unit(s) and an extended release matrix
JP5275560B2 (ja) * 2006-10-24 2013-08-28 小林化工株式会社 酒石酸ゾルピデム含有素錠の製造方法
EP1938805A1 (de) * 2006-12-22 2008-07-02 LEK Pharmaceuticals D.D. Monolithische Zolpidemtabletten mit verzögerter Freisetzung
EP1970056A1 (de) * 2007-03-15 2008-09-17 Polichem S.A. Zeitspezifische Dosierformen mit verzögerter/pulsatiler Freisetzung
WO2009021127A2 (en) * 2007-08-07 2009-02-12 Neurogen Corporation Controlled released compositions
CA2721493C (en) 2008-04-18 2017-11-28 Intec Pharma Ltd. Carbidopa/levodopa gastroretentive drug delivery
US20100068283A1 (en) 2008-09-16 2010-03-18 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Ex VIVO modifiable particle or polymeric material medicament carrier
JP2012510987A (ja) * 2008-12-04 2012-05-17 インテック ファーマ リミテッド ザレプロン胃内滞留性薬剤送達システム
RU2384336C1 (ru) * 2009-04-22 2010-03-20 Маргарита Алексеевна Морозова Фармацевтический состав для коррекции психосоматических проявлений
JP5628910B2 (ja) * 2009-07-07 2014-11-19 サノビオン ファーマシューティカルズ インクＳｕｎｏｖｉｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃ． ６−（５−クロロ−２−ピリジル）−５−［（４−メチル−１−ピペラジニル）カルボニルオキシ］−７−オキソ−６，７−ジヒドロ−５ｈ−ピロロ［３，４−ｂ］ピラジンの配合物
FR2949062B1 (fr) * 2009-08-12 2011-09-02 Debregeas Et Associes Pharma Nouvelles formulations pharmaceutiques contre le mesusage des medicaments
GB201003766D0 (en) * 2010-03-05 2010-04-21 Univ Strathclyde Pulsatile drug release
GB201003734D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Delayed prolonged drug delivery
GB201003731D0 (en) 2010-03-05 2010-04-21 Univ Strathclyde Immediate/delayed drug delivery
FR2968992B1 (fr) * 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
FR2968995B1 (fr) * 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
TWI505841B (zh) * 2011-09-29 2015-11-01 Taiwan Biotech Co Ltd 治療睡眠障礙之控釋調配物
MX373821B (es) * 2014-02-06 2020-03-24 Sequential Medicine Ltd Composición y método para ayudar a dormir.
RU2659200C1 (ru) * 2017-07-24 2018-06-28 Общество С Ограниченной Ответственностью "Валента - Интеллект" Фармацевтический состав, содержащий алимемазина тартрат

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8404467D0 (sv) * 1984-09-06 1984-09-06 Ferrosan Ab Controlled-release medical preparations
GB2185887B (en) * 1987-02-18 1989-12-06 Farmitalia Carlo Erba Ltd Temazepam composition
ES2058546T3 (es) * 1988-09-30 1994-11-01 Rhone Poulenc Rorer Ltd Formulaciones farmaceuticas granulares.
FR2656303B1 (fr) * 1989-12-26 1994-06-10 Parke Davis Solution buvable d'un derive des benzodiazepines et son application pharmacologique.
IE61651B1 (en) * 1990-07-04 1994-11-16 Zambon Spa Programmed release oral solid pharmaceutical dosage form
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale
US5837284A (en) * 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
FR2742660B1 (fr) * 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
HRP970493A2 (en) * 1996-09-23 1998-08-31 Wienman E. Phlips Oral delayed immediate release medical formulation and method for preparing the same
BR9802915A (pt) * 1997-09-12 2000-01-11 Oscar Gold Procedimento para formar composições farmaceuticas em pilulas ou granulos substancialmente esfericos, de ação controlada e continuada, contendo como agente ativo o (7-bromo-1,3-diidro-5-(2-piridninilo)-2h-1,4-benzodiazep ina-2(1h)-um)
US6066339A (en) * 1997-10-17 2000-05-23 Elan Corporation, Plc Oral morphine multiparticulate formulation
FR2772615B1 (fr) * 1997-12-23 2002-06-14 Lipha Comprime multicouche pour la liberation instantanee puis prolongee de substances actives
EP1005863A1 (de) * 1998-12-04 2000-06-07 Synthelabo Dosisformen mit gesteuerter Wirkstofffreigabe enthaltend ein kurzer wirkung Hypnotikum oder einem Salz davon

Also Published As

Publication number Publication date
PT1194132E (pt) 2004-10-29
CN1358087A (zh) 2002-07-10
CO5190680A1 (es) 2002-08-29
DK1194132T3 (da) 2004-10-11
DE60011617T2 (de) 2005-06-09
MXPA01013212A (es) 2002-06-21
TWI285118B (en) 2007-08-11
SI1194132T1 (en) 2004-10-31
CN100415216C (zh) 2008-09-03
ZA200110005B (en) 2003-02-26
BR0011994A (pt) 2002-03-05
AR024491A1 (es) 2002-10-02
WO2001000181A3 (en) 2001-03-01
SK19112001A3 (sk) 2002-05-09
PL357348A1 (en) 2004-07-26
HU227810B1 (en) 2012-03-28
AU6694400A (en) 2001-01-31
IL146928A0 (en) 2002-08-14
HUP0201907A3 (en) 2004-05-28
JP2003503340A (ja) 2003-01-28
EP1194132A2 (de) 2002-04-10
CZ20014640A3 (cs) 2002-03-13
CA2370556A1 (en) 2001-01-04
EP1064937A1 (de) 2001-01-03
AU782162B2 (en) 2005-07-07
NZ515997A (en) 2004-03-26
DE60011617D1 (de) 2004-07-22
KR20020015064A (ko) 2002-02-27
SK285347B6 (sk) 2006-11-03
WO2001000181A2 (en) 2001-01-04
NO20016283L (no) 2002-02-27
TR200103594T2 (tr) 2002-06-21
HUP0201907A2 (hu) 2002-12-28
PL201777B1 (pl) 2009-05-29
CA2370556C (en) 2009-09-01
HK1043057A1 (en) 2002-09-06
HK1043057B (en) 2005-02-25
ES2222223T3 (es) 2005-02-01
NO20016283D0 (no) 2001-12-20
EP1194132B1 (de) 2004-06-16

Similar Documents

Publication Publication Date Title
ATE269062T1 (de) Zeitgesteuert freisetzende dosierungsformen enthaltend ein kurz wirksames hypnotikum oder ein salz davon
DK1204410T3 (da) Farmaceutisk doseringsform med flere komponenter
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
ATE267178T1 (de) Diazepinderivate oder deren salze
PT1307457E (pt) Compostos heterociclicos sua preparacao e utilizacao como medicamentos noemadamente como antibacterianos
HU0004123D0 (en) New compounds with pharmaceutical activity
ATE411068T1 (de) Medikamentspender
DE60010824T2 (de) Katheter zur intermittierenden Selbst-Ableitung von Urin
DK1207868T3 (da) Farmaceutiske tramadolsalte
EE200300055A (et) Hüdrogeeli poolt juhitav ravimi annustamisvorm
ATE419231T1 (de) Mono-substituierte 3-propyl-gamma- aminobuttersäure
EE200200012A (et) Suukaudselt manustatav maskeeritud maitsega vedelpreparaat
DK79098A (da) Selvborende dyvel
NO20014926D0 (no) Farmasöytiske forbindelser
DE60045592D1 (de) Benachbart montierbare Sensoreinheit
ATE237529T1 (de) Tablettenspender
DE69903293D1 (de) Überrollsensor mit nebenschluss
ATE302262T1 (de) Reinigungszusammensetzung enthaltend ein schmutzabsorbierendes system
ATE294804T1 (de) Pharmazeutische zusammensetzung enthaltend ein farnesyl-transferase hemmenden 1,2-annellierten chinolin enantiomer
NO20016430L (no) Farmasöytisk kompleks
DE60023341D1 (de) Orale lösung enthaltend galanthamine und ein süssungsmittel
EP1361283A4 (de) Neues assay-verfahren
IS6007A (is) Ný morfólínóbensamíðsölt
EP1270737A4 (de) Testverfahren mit vorinkubationsschritt
EE200300045A (et) Kristalne ravimaine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1194132

Country of ref document: EP